You have 9 free searches left this month | for more free features.

City

Condition

Metastatic Castration-Resistant Prostate Cancer (mCRPC) (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

[177lu]lu-psma-617 (2)

68ga-psma-11 (1)

[68ga]ga-psma-11 (1)

ardt (1)

best supportive care (1)

best supportive/best standard of care (bs/bsoc) (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

[177lu]lu-psma-617

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care

Not yet recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

[177Lu]Lu-PSMA-617
+2 more

(no location specified)

Jan 2, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

[177Lu]Lu-PSMA-617
+3 more

(no location specified)

Jan 23, 2023